Juan Jesús
Gómez-Reino Carnota
Charles University in Prague
Praga, República ChecaPublicacións en colaboración con investigadores/as de Charles University in Prague (12)
2022
-
After JAK inhibitor failure: To cycle or to switch, that is the question - Data from the JAK-pot collaboration of registries
Annals of the Rheumatic Diseases, Vol. 82, Núm. 2, pp. 175-181
2019
-
Treatment response and drug retention rates in 24 195 biologic-naïve patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration
Annals of the Rheumatic Diseases, Vol. 78, Núm. 11, pp. 1536-1544
2017
-
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update
Annals of the Rheumatic Diseases, Vol. 76, Núm. 6, pp. 960-977
2016
-
Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: Data from the CERERRA collaboration
Arthritis Research and Therapy, Vol. 18, Núm. 1
-
Erratum to: Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: Data from the CERERRA collaboration [Arthritis Res Ther. 18: (2016); 50], doi: 10.1186/s13075-016-0951-z
Arthritis Research and Therapy
2013
-
Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions
Annals of the Rheumatic Diseases, Vol. 72, Núm. 4, pp. 482-492
2012
-
Effectiveness of disease-modifying antirheumatic drug co-therapy with methotrexate and leflunomide in rituximab-treated rheumatoid arthritis patients: Results of a 1-year follow-up study from the CERERRA collaboration
Annals of the Rheumatic Diseases, Vol. 71, Núm. 3, pp. 374-377
2011
-
Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: Pooled data from 10 European registries
Annals of the Rheumatic Diseases, Vol. 70, Núm. 9, pp. 1575-1580
-
Treating rheumatoid arthritis to target: Multinational recommendations assessment questionnaire
Annals of the Rheumatic Diseases, Vol. 70, Núm. 11, pp. 1999-2002
2010
-
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs
Annals of the Rheumatic Diseases, Vol. 69, Núm. 6, pp. 964-975
-
The Eular recommendations for the management of rheumatoid arthritis with synthetic disease-modifying antirheumatic drugs
Rheumatologia, Vol. 24, Núm. 4, pp. 143-158
2007
-
Consensus statement on the use of rituximab in patients with rheumatoid arthritis
Annals of the Rheumatic Diseases, Vol. 66, Núm. 2, pp. 143-150